Innovative Non-Invasive Monitoring Cheetah Medical specializes in non-invasive cardiac output and hemodynamic monitoring technologies that are recognized globally, offering a compelling alternative to traditional invasive methods. This positions the company as a leader in minimally invasive solutions, opening opportunities to expand adoption in hospitals seeking safer, quicker diagnostics.

Strong Clinical Validation With FDA clearance and CE marking for its flagship systems, Cheetah’s products have validated clinical efficacy, which can appeal to healthcare providers and hospitals looking for reliable, regulatory-approved monitoring tools to improve patient outcomes.

Recent Acquisition Momentum Major acquisitions by Baxter Group and Greystoneassociates demonstrate a growing industry interest and validation of Cheetah’s technology. These acquisitions hint at increased investment capacity, potential for market expansion, and opportunities to leverage partners’ distribution channels.

Growth and Funding Potential Although the company's revenue is modest compared to industry giants, recent Series C funding and strategic expansion efforts suggest strong growth potential, making Cheetah an attractive prospect for medical institutions seeking innovative, scalable hemodynamic monitoring solutions.

Global Market Presence With headquarters in the US, Israel, and Oregon, and installed systems worldwide, Cheetah offers an international footprint that can be leveraged to target expanding markets, especially in regions looking to adopt non-invasive critical care technologies.